West Oak Capital’s Pulse Biosciences PLSE Stock Holding History

West Oak Capital’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100	Closed	-$2K	–	379
2021 Q2	$2K	Hold	100	–	–	﹤0.01%	320
2021 Q1	$2K	Hold	100	–	–	﹤0.01%	310
2020 Q4	$2K	Hold	100	–	–	﹤0.01%	287
2020 Q3	$1K	Hold	100	–	–	﹤0.01%	286
2020 Q2	$1K	Hold	100	–	–	﹤0.01%	291
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	274
2019 Q4	$1K	Hold	100	–	–	﹤0.01%	274
2019 Q3	$2K	Hold	100	–	–	﹤0.01%	280
2019 Q2	$1K	Hold	100	–	–	﹤0.01%	310
2019 Q1	$2K	Hold	100	–	–	﹤0.01%	292
2018 Q4	$1.15K	Hold	100	–	–	﹤0.01%	319
2018 Q3	$1.42K	Hold	100	–	–	﹤0.01%	345
2018 Q2	$1.51K	Hold	100	–	–	﹤0.01%	311
2018 Q1	$1.35K	Buy	+100	New	+$1.9K	﹤0.01%	323

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

West Oak Capital's PLSE Position: Q3 2021 in Review

West Oak Capital sold out of Pulse Biosciences (PLSE) in Q3 2021, closing a stake of 100 shares — an estimated $2K sold.

West Oak Capital first reported a position in PLSE in Q1 2018 and held it in 14 quarters. The position peaked at $2K in Q2 2021. 55 funds tracked by Wall St. Rank hold PLSE as of Q3 2021.

West Oak Capital reported no remaining Pulse Biosciences position as of Q3 2021 after selling out during the quarter.
West Oak Capital sold 100 Pulse Biosciences shares in Q3 2021, an estimated $2K.
West Oak Capital first reported a position in Pulse Biosciences in Q1 2018 and held it in 14 quarters.
West Oak Capital's Pulse Biosciences position peaked at $2K in Q2 2021.
55 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2021.

Based on West Oak Capital's 13F filing for Q3 2021, filed 7 Oct 2021.